690 results on '"Prentice, H. G."'
Search Results
2. Detection of Minimal Residual Disease in B-Lineage Leukemia by Immunoglobulin Gene Fingerprinting
3. The Addition of Granulocyte-Macrophage Colony-Stimulating Factor to Normal Bone Marrow Enhances Cell Cycle and Clonogenicity Irrespective of Cryopreservation
4. The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients
5. A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation
6. Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients
7. Identification of non-naïve CD4+CD45RA+ T cell subsets in adult allogeneic haematopoietic cell transplant recipients
8. Granisetron in the control of nausea and vomiting associated with bone marrow transplantation: a review of its efficacy and tolerability
9. Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy
10. Splenectomy as first immunosuppressive treatment option for refractory autoimmune cytopenias after allogeneic HSCT
11. Risk factors for viral reactivation following bone marrow transplantation
12. Mycobacterium tuberculosis infection following allogeneic peripheral blood stem cell transplantation
13. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B
14. Anti-CD20 monoclonal antibody (rituximab) therapy in a child with refractory chronic autoimmune haemolytic anaemia
15. In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy
16. Toxoplasmosis following allogeneic hematopoietic stem cell transplantation
17. Reduced-intensity allogeneic transplantation using BEAM-Campath in patients with lymphoproliferative diseases – GVHD, toxicity and survival in 65 patients
18. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function – implications for the adoptive immunotherapy of leukaemia
19. Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG ± Ida) and second allogeneic stem cell transplant
20. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
21. The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients
22. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study
23. Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
24. THE DEVELOPMENT OF RSCA AS A METHOD OF ANALYSING THE T CELL RECEPTOR REPERTOIRE DIVERSITY: APPLICATION IN BONE MARROW TRANSPLANTATION
25. RECONSTITUTION OF THE T-CELL COMPARTMENT POST-ALLOGENEIC STEM CELL TRANSPLANT
26. TARGETED RADIOTHERAPY FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES: PRE-CLINICAL EVALUATION OF A RADIOLABELLED MONOCLONAL ANTI-CD45 ANTIBODY FOR TRANSPLANT CONDITIONING AND INITIAL CLINICAL DOSIMETRY RESULTS.
27. THE AKT PROTEIN KINASE MEDIATES PLASMA-INDUCED SURVIVAL OF B-CLL CELLS.
28. ACTIVATION OF CASPASE 8 IN THE ABSENCE OF FAS LIGATION IN THE KILLING OF B-CLL CELLS BY CYTOTOXIC DRUGS AND RADIATION.
29. PREDICTING CLINICAL OUTCOME IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA BY MONITORING MINIMAL RESIDUAL DISEASE.
30. INCREASE IN CYTOPLASMIC CYTOCHROME C IS NOT A RATELIMITING STEP IN THE INDUCTION OF APOPTOSIS OF B-CLL CELLS.
31. GENE EXPRESSION OF MULTIDRUG RESISTANT PROTEIN (MRP) HOMOLOGUES IN B-CLL AND AML CELLS.
32. A HIGHLY IMMUNOSUPPRESSIVE CONDITIONING REGIMEN FOR HIGH RISK PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
33. HIGH RATE OF CMV REACTIVATION (BUT NOT DISEASE) IN RECIPIENTS OF ALLOGENEIC TRANSPLANTS CONDITIONED WITH CAMPATH 1H
34. THE USE OF FLUORO-DEOXYGLUCOSE (FDG) PET IMAGING FOR THE DETECTION OF OCCULT DISEASE IN MULTIPLE MYELOMA.
35. COMBINATION OF AZOLES AND AMPHOTERICIN B SUSPENSION FOR THE PREVENTION OF CANDIDA COLONISATION AND INFECTIONS.
36. Oral and Intravenous Itraconazole for Systemic Fungal Infections in Neutropenic Haematological Patients: Meeting Report
37. NK cell recognition of CMV infected target cells: Role of MHC class I and adhesion molecule expression
38. Detection of Minimal Residual Disease in B-Lineage Leukemia by Immunoglobulin Gene Fingerprinting
39. Understanding the Mechanisms of Cure in Acute Myeloblastic Leukaemia: Towards a Modern Immunotherapy
40. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
41. Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid
42. Incidence of Ph1 Positive All in Unselected, Population-Based Study of Adult All
43. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA
44. Idiopathic myelofibrosis in children
45. Acute myeloblastic leukaemia presenting with herpes simplex type-1 viraemia and pneumonia
46. Yersinia enterocolitica transmission from a red cell unit 34 days old
47. Chaetomium pneumonia in patient with acute myeloid leukaemia
48. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation
49. Donor-specific bone marrow infusion after orthotopic liver transplantation
50. Ingrowing toenails and cyclosporin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.